Glycoscience

Lacto-N-fucopentaose II-BSA is a glycosylation agent that is derived from the natural substrate N-acetylgalactosamine. It is used in the synthesis of complex carbohydrates, such as glycoconjugates and polysaccharides. Lacto-N-fucopentaose II-BSA can be modified with methyl groups or fluorine atoms to generate derivatives, which are useful for studying glycosylation reactions. The CAS number for this product is 46645-96-8. This product is synthesized using custom methods and has been purified to high purity levels.

1-Deoxy-L-ribose is a metabolite of acetone. It is a monosaccharide that contains one less oxygen atom than its parent compound. 1-Deoxy-L-ribose is found in the urine and blood of humans and animals. In animals, it can be synthesized from glucose by the enzyme ribose 1-phosphate reductase. This reaction requires an energy source such as ATP or NADH to reduce ribose 1,5-bisphosphate to 1,4-dihydroxyacetone phosphate, which then undergoes spontaneous dehydration to form 1-deoxy-D-ribose.

L-altronojirimycin is a diterpene glycoside that belongs to the group of natural products that have inhibitory properties against lipid peroxidation. It has been shown to decrease the concentration of 1,2-dipalmitoylglycerophosphocholine (DPPC) in primary cells and reduce the rate of lipid peroxidation in a concentration-dependent manner. L-altronojirimycin inhibits the activity of enzymes such as acetylcholinesterase and phospholipase A2, which are involved in inflammation. This drug has also been shown to have cardioprotective effects and inhibit mutations in cardiac muscle cells. L-altronojirimycin has been tested for its long-term efficacy and shown to be effective against both bowel disease and cardiac effects.

Glcnacβ(1-3)GalNAc-α-Thr is a polysaccharide that is found in the human body, which is a complex carbohydrate. It is an oligosaccharide modification of galactose and alpha-threonine. Glcnacβ(1-3)GalNAc-α-Thr can be custom synthesized to order with high purity and monosaccharide content. This product is used for research purposes and has not been approved for therapeutic use. The CAS number for this compound is 286959-52-2.

Methyl 2,3,4-tri-O-acetyl-b-L-thiofucopyranoside is a ferrite that is important for the growth of cells. It can be used as a growth factor to promote the growth of cells. Covid®-19 pandemic A/Aureus strain is resistant to this drug and it has been shown to inhibit cellular transformation in human epidermal cells. The drug also reduces the size and number of cancerous lesions in mice by inhibiting tumor angiogenesis. Methyl 2,3,4-tri-O-acetyl-b-L-thiofucopyranoside can cause an overload of Ca2+ ions in the cell, which may lead to apoptosis or necrosis.